The landmark clinical trial CuRe Trial: Cellular Therapy for In Utero Repair of Myelomeningocele is underway at UC Davis Health. The world’s first spina bifida treatment combining fetal surgery with stem cells could change the life of a baby with spina bifida, who could otherwise be paralyzed from the waist down.
Christian was the 14th patient to undergo fetal surgery for myelomeningocele, a severe form of spina bifida, at Children’s Hospital of Philadelphia. He is now a tall, handsome 24-year-old who recently passed his national certification to become an emergency medical technician (EMT).
5-minute read
The Badenhop family wasn’t expecting news of spina bifida and were scared and uncertain about their baby’s future. But Nationwide Children’s Hospital’s expert team offered hope — and a successful outcome for baby Lexi.
5-minute read
A young mom is faced with life or death decisions soon after learning her son’s diagnosis of spina bifida and hydrocephalus. She tells us her heartwarming story.
4-minute read
Researchers at UC Davis Health are continuing to Phase 2 of a clinical trial for in utero surgery that uses stem cells to repair spina bifida defect, offering potential better outcomes.
When Katarina’s unborn baby was diagnosed with myelomeningocele (MMC), “It was kind of a shock, but my doctor said the best bet was fetal surgery. He referred me to Colorado right away, and he said we needed to do it as soon as possible,” she says. “That just kind of threw me for a whirlwind, and I have other kids to take care of too. It was a lot to process.”